Related Experiment Video

Updated: May 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary

Hai-Yan Xu1, Shu-Bin Qiao, Jia-Fen Zhang

  • 1Department of Dyslipidemia, Chinese Academy of Medical Sciences, Beijing, China.

Coronary Artery Disease
|February 17, 2012
PubMed

Insights

Inflammation marker C-reactive protein (CRP) before and after percutaneous coronary intervention (PCI) is linked to in-stent restenosis (ISR). Lipid profiles, including total cholesterol and LDL-C, are associated with coronary lesion progression post-PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarkers

Background:

  • In-stent restenosis (ISR) and lesion progression are significant complications following percutaneous coronary intervention (PCI).
  • The roles of inflammation and lipid profiles in these adverse events remain debated.
  • Understanding these factors is crucial for improving long-term outcomes after PCI.

Purpose of the Study:

  • To investigate the impact of inflammation and lipid profiles on ISR.
  • To examine the association between inflammation and lipid profiles and coronary lesion progression.
  • To identify predictive markers for adverse events after PCI.

Main Methods:

  • Retrospective analysis of 513 patients undergoing PCI with follow-up angiography.
  • Analysis of pre-PCI and follow-up lipid profiles and C-reactive protein (CRP) levels.
  • Comparison of ISR and lesion progression groups with a control group.

Main Results:

  • Pre-PCI CRP levels were higher in the ISR group compared to controls.
  • Pre-PCI and follow-up CRP levels correlated significantly with ISR.
  • Elevated total cholesterol, LDL-C, and non-HDL-C at follow-up were associated with lesion progression.

Conclusions:

  • Pre-PCI CRP levels are strongly associated with in-stent restenosis.
  • Diabetes and serum lipid levels (TC, LDL-C, non-HDL-C) correlate with coronary lesion progression.
  • Inflammation and lipid profiles are key factors in PCI outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...